| 0 |
VISUAL ACUITY TESTS NORMAL |
1 |
0.5000 |
| 1 |
GRIP STRENGTH |
105 |
0.4585 |
| 2 |
HYALURONIC ACID DECREASED |
1 |
0.3333 |
| 3 |
DERMAL FILLER OVERCORRECTION |
1 |
0.3333 |
| 4 |
SWOLLEN JOINT COUNT |
61 |
0.2440 |
| 5 |
PURTSCHER RETINOPATHY |
16 |
0.1951 |
| 6 |
SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, HYPERSOMNIA TYPE |
15 |
0.1429 |
| 7 |
DEEP VEIN THROMBOSIS POSTOPERATIVE |
236 |
0.1178 |
| 8 |
PAROPHTHALMIA |
27 |
0.1134 |
| 9 |
SCLERAL DEGENERATION |
1 |
0.1111 |
| 10 |
TENDER JOINT COUNT |
9 |
0.1071 |
| 11 |
LUPUS VULGARIS |
134 |
0.1063 |
| 12 |
SWOLLEN JOINT COUNT ABNORMAL |
2 |
0.1053 |
| 13 |
C-REACTIVE PROTEIN |
87 |
0.0939 |
| 14 |
PORPHYRIA ACUTE |
132 |
0.0920 |
| 15 |
ACUTE MACULAR NEURORETINOPATHY |
15 |
0.0877 |
| 16 |
X-RAY ABNORMAL |
152 |
0.0849 |
| 17 |
ACQUIRED PORPHYRIA |
6 |
0.0845 |
| 18 |
RETINITIS |
137 |
0.0792 |
| 19 |
VACCINATION SITE DISCOLOURATION |
1 |
0.0769 |
| 20 |
ADJUSTMENT DISORDER WITH DEPRESSED MOOD |
156 |
0.0752 |
| 21 |
ELECTROCARDIOGRAM T WAVE AMPLITUDE INCREASED |
7 |
0.0745 |
| 22 |
ASIA SYNDROME |
1 |
0.0667 |
| 23 |
TRIGEMINAL PALSY |
3 |
0.0652 |
| 24 |
SWOLLEN JOINT COUNT INCREASED |
201 |
0.0630 |
| 25 |
DISLOCATION OF VERTEBRA |
143 |
0.0626 |
| 26 |
PIK3CA RELATED OVERGROWTH SPECTRUM |
1 |
0.0625 |
| 27 |
OCULOCARDIAC REFLEX |
1 |
0.0625 |
| 28 |
FACET JOINT SYNDROME |
202 |
0.0620 |
| 29 |
CONJUNCTIVAL BLEB |
3 |
0.0556 |
| 30 |
LAGOPHTHALMOS |
20 |
0.0489 |
| 31 |
RHEUMATIC FEVER |
217 |
0.0486 |
| 32 |
PERIPHERAL VENOUS DISEASE |
196 |
0.0479 |
| 33 |
ANTIPHOSPHOLIPID ANTIBODIES |
9 |
0.0462 |
| 34 |
SUPERIOR SEMICIRCULAR CANAL DEHISCENCE |
1 |
0.0435 |
| 35 |
CORNEAL GRAFT FAILURE |
1 |
0.0435 |
| 36 |
OPEN GLOBE INJURY |
7 |
0.0424 |
| 37 |
BONE EROSION |
138 |
0.0390 |
| 38 |
RETINAL WHITE DOTS SYNDROME |
1 |
0.0385 |
| 39 |
C-REACTIVE PROTEIN ABNORMAL |
238 |
0.0371 |
| 40 |
CAVERNOUS SINUS SYNDROME |
1 |
0.0370 |
| 41 |
DUODENAL ULCER PERFORATION |
259 |
0.0348 |
| 42 |
SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE |
226 |
0.0348 |
| 43 |
RHEUMATOID FACTOR POSITIVE |
200 |
0.0346 |
| 44 |
ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE |
238 |
0.0332 |
| 45 |
DRUG TOLERANCE DECREASED |
91 |
0.0324 |
| 46 |
HYPOCHOLESTEROLAEMIA |
11 |
0.0312 |
| 47 |
INTRAOCULAR PRESSURE FLUCTUATION |
6 |
0.0305 |
| 48 |
NODAL MARGINAL ZONE B-CELL LYMPHOMA |
1 |
0.0294 |
| 49 |
SOFT TISSUE ATROPHY |
2 |
0.0282 |
| 50 |
SKIN LAXITY |
12 |
0.0274 |
| 51 |
MUSCLE INJURY |
226 |
0.0272 |
| 52 |
AUTOIMMUNE DISORDER |
259 |
0.0265 |
| 53 |
XANTHELASMA |
3 |
0.0261 |
| 54 |
HELICOBACTER INFECTION |
265 |
0.0258 |
| 55 |
THECAL SAC COMPRESSION |
1 |
0.0256 |
| 56 |
CONJUNCTIVAL OEDEMA |
25 |
0.0243 |
| 57 |
PRODUCT SELECTION ISSUE |
1 |
0.0238 |
| 58 |
BREAST CANCER STAGE III |
153 |
0.0236 |
| 59 |
FOLLICULITIS |
244 |
0.0232 |
| 60 |
LIP DRY |
210 |
0.0231 |
| 61 |
DISORDER OF ORBIT |
3 |
0.0208 |
| 62 |
MATERNAL EXPOSURE TIMING UNSPECIFIED |
75 |
0.0199 |
| 63 |
BURSITIS |
241 |
0.0198 |
| 64 |
ORBITAL OEDEMA |
10 |
0.0198 |
| 65 |
HAND DEFORMITY |
246 |
0.0187 |
| 66 |
ORBITAL COMPARTMENT SYNDROME |
1 |
0.0182 |
| 67 |
PEMPHIGUS |
222 |
0.0177 |
| 68 |
CELLULITIS ORBITAL |
10 |
0.0172 |
| 69 |
ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY |
11 |
0.0165 |
| 70 |
GRIP STRENGTH DECREASED |
143 |
0.0162 |
| 71 |
MYOPATHY TOXIC |
10 |
0.0162 |
| 72 |
ADMINISTRATION SITE SCAR |
1 |
0.0161 |
| 73 |
JOINT RANGE OF MOTION DECREASED |
206 |
0.0153 |
| 74 |
LUPUS-LIKE SYNDROME |
136 |
0.0150 |
| 75 |
FACIAL WASTING |
4 |
0.0149 |
| 76 |
WOUND INFECTION |
162 |
0.0148 |
| 77 |
MISOPHONIA |
1 |
0.0147 |
| 78 |
PERIORBITAL DISORDER |
3 |
0.0146 |
| 79 |
OCULAR RETROBULBAR HAEMORRHAGE |
2 |
0.0144 |
| 80 |
LYMPHANGIECTASIA |
1 |
0.0143 |
| 81 |
EXOSTOSIS |
128 |
0.0140 |
| 82 |
MUSCLE FIBROSIS |
1 |
0.0137 |
| 83 |
SCIATICA |
218 |
0.0137 |
| 84 |
MENINGITIS CHEMICAL |
3 |
0.0136 |
| 85 |
HYPERCHOLESTEROLAEMIA |
131 |
0.0136 |
| 86 |
LID SULCUS DEEPENED |
5 |
0.0134 |
| 87 |
PERICARDITIS |
218 |
0.0130 |
| 88 |
STIFF TONGUE |
1 |
0.0123 |
| 89 |
LOCAL ANAESTHETIC SYSTEMIC TOXICITY |
13 |
0.0122 |
| 90 |
EYE OPERATION COMPLICATION |
2 |
0.0122 |
| 91 |
OBESITY |
194 |
0.0122 |
| 92 |
SYNOVITIS |
214 |
0.0119 |
| 93 |
WALKING AID USER |
78 |
0.0118 |
| 94 |
OCULAR ISCHAEMIC SYNDROME |
1 |
0.0118 |
| 95 |
LOWER LIMB FRACTURE |
225 |
0.0117 |
| 96 |
EXOPHTHALMOS |
25 |
0.0116 |
| 97 |
FOOT DEFORMITY |
125 |
0.0113 |
| 98 |
SUBCUTANEOUS DRUG ABSORPTION IMPAIRED |
6 |
0.0107 |
| 99 |
GLOSSODYNIA |
236 |
0.0105 |
| 100 |
SERONEGATIVE ARTHRITIS |
12 |
0.0105 |
| 101 |
MULTIPLE DRUG HYPERSENSITIVITY |
1 |
0.0104 |
| 102 |
JOINT DESTRUCTION |
16 |
0.0103 |
| 103 |
FIBROMYALGIA |
239 |
0.0098 |
| 104 |
ADENOCARCINOMA METASTATIC |
2 |
0.0097 |
| 105 |
IRRITABLE BOWEL SYNDROME |
206 |
0.0096 |
| 106 |
LIVER INJURY |
202 |
0.0082 |
| 107 |
CONGENITAL ANOMALY |
63 |
0.0081 |
| 108 |
PULMONARY FIBROSIS |
153 |
0.0080 |
| 109 |
WOUND |
221 |
0.0079 |
| 110 |
RED BLOOD CELL SEDIMENTATION RATE INCREASED |
87 |
0.0079 |
| 111 |
HEPATIC CIRRHOSIS |
143 |
0.0076 |
| 112 |
HIP ARTHROPLASTY |
114 |
0.0074 |
| 113 |
TYPE 2 DIABETES MELLITUS |
250 |
0.0074 |
| 114 |
DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY |
7 |
0.0074 |
| 115 |
JOINT DISLOCATION |
78 |
0.0074 |
| 116 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
125 |
0.0074 |
| 117 |
LYMPHANGIOMA |
1 |
0.0072 |
| 118 |
VASCULAR STENT STENOSIS |
3 |
0.0071 |
| 119 |
IMPAIRED HEALING |
229 |
0.0070 |
| 120 |
DERMATOCHALASIS |
1 |
0.0068 |
| 121 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
241 |
0.0068 |
| 122 |
CAUDA EQUINA SYNDROME |
5 |
0.0065 |
| 123 |
LIVE BIRTH |
54 |
0.0064 |
| 124 |
RETINAL ARTERY OCCLUSION |
16 |
0.0063 |
| 125 |
EXTRAOCULAR MUSCLE DISORDER |
2 |
0.0062 |
| 126 |
PRESCRIBED OVERDOSE |
119 |
0.0061 |
| 127 |
NIGHT SWEATS |
198 |
0.0061 |
| 128 |
CARDIOACTIVE DRUG LEVEL ABOVE THERAPEUTIC |
1 |
0.0060 |
| 129 |
ANAESTHETIC COMPLICATION |
16 |
0.0060 |
| 130 |
PNEUMONIA PARAINFLUENZAE VIRAL |
1 |
0.0059 |
| 131 |
PELVIC FLOOR MUSCLE WEAKNESS |
1 |
0.0058 |
| 132 |
CARDIOACTIVE DRUG LEVEL DECREASED |
1 |
0.0058 |
| 133 |
VACCINATION SITE SWELLING |
1 |
0.0058 |
| 134 |
BLOOD OESTROGEN ABNORMAL |
1 |
0.0058 |
| 135 |
PREGNANCY |
116 |
0.0058 |
| 136 |
HYPHAEMA |
3 |
0.0057 |
| 137 |
BLOOD CHOLESTEROL INCREASED |
268 |
0.0057 |
| 138 |
WEIGHT FLUCTUATION |
60 |
0.0057 |
| 139 |
EYELASH CHANGES |
1 |
0.0056 |
| 140 |
PROCEDURAL FAILURE |
1 |
0.0056 |
| 141 |
KNEE ARTHROPLASTY |
118 |
0.0056 |
| 142 |
ROAD TRAFFIC ACCIDENT |
234 |
0.0056 |
| 143 |
TOXIC ANTERIOR SEGMENT SYNDROME |
6 |
0.0055 |
| 144 |
ANAESTHESIA |
2 |
0.0055 |
| 145 |
OSTEOARTHRITIS |
230 |
0.0054 |
| 146 |
LOWER RESPIRATORY TRACT INFECTION |
245 |
0.0054 |
| 147 |
ASPARTATE AMINOTRANSFERASE ABNORMAL |
8 |
0.0052 |
| 148 |
PSORIATIC ARTHROPATHY |
213 |
0.0052 |
| 149 |
OCULAR PROCEDURAL COMPLICATION |
1 |
0.0052 |
| 150 |
BLOOD PHOSPHORUS INCREASED |
14 |
0.0051 |
| 151 |
EAR INFECTION |
131 |
0.0049 |
| 152 |
LIVER DISORDER |
218 |
0.0049 |
| 153 |
OPTIC ATROPHY |
8 |
0.0049 |
| 154 |
SYSTEMIC TOXICITY |
1 |
0.0049 |
| 155 |
FREQUENT BOWEL MOVEMENTS |
131 |
0.0048 |
| 156 |
DELIRIUM |
163 |
0.0047 |
| 157 |
ARTHROPATHY |
258 |
0.0046 |
| 158 |
VACCINATION SITE ERYTHEMA |
1 |
0.0046 |
| 159 |
BLISTER |
250 |
0.0044 |
| 160 |
ANAESTHETIC COMPLICATION NEUROLOGICAL |
4 |
0.0044 |
| 161 |
DISCOMFORT |
267 |
0.0044 |
| 162 |
LUNG DISORDER |
214 |
0.0044 |
| 163 |
INFUSION SITE REACTION |
13 |
0.0043 |
| 164 |
MUSCLE SWELLING |
4 |
0.0043 |
| 165 |
BREAKTHROUGH COVID-19 |
1 |
0.0043 |
| 166 |
PERIORBITAL INFLAMMATION |
1 |
0.0043 |
| 167 |
RESPIRATORY DISORDER |
129 |
0.0043 |
| 168 |
STOMATITIS |
258 |
0.0042 |
| 169 |
RETINAL DYSTROPHY |
1 |
0.0042 |
| 170 |
INTRAOCULAR PRESSURE TEST |
1 |
0.0042 |
| 171 |
INFECTIVE SPONDYLITIS |
1 |
0.0041 |
| 172 |
BREAST CANCER STAGE II |
34 |
0.0041 |
| 173 |
STRABISMUS |
12 |
0.0041 |
| 174 |
FOREIGN BODY REACTION |
1 |
0.0041 |
| 175 |
ILLNESS ANXIETY DISORDER |
1 |
0.0041 |
| 176 |
MUSCULOSKELETAL PAIN |
213 |
0.0041 |
| 177 |
HEPATIC ENZYME INCREASED |
275 |
0.0040 |
| 178 |
SOFT TISSUE INJURY |
3 |
0.0040 |
| 179 |
EYE INJURY |
12 |
0.0039 |
| 180 |
AUTOPHOBIA |
1 |
0.0039 |
| 181 |
CATARACT OPERATION COMPLICATION |
2 |
0.0039 |
| 182 |
CORNEAL THINNING |
1 |
0.0039 |
| 183 |
RECTAL HAEMORRHAGE |
167 |
0.0039 |
| 184 |
RED BLOOD CELL SEDIMENTATION RATE DECREASED |
1 |
0.0038 |
| 185 |
OPHTHALMOPLEGIA |
6 |
0.0038 |
| 186 |
GAIT INABILITY |
127 |
0.0038 |
| 187 |
INFLAMMATION |
195 |
0.0038 |
| 188 |
OPTIC NERVE DISORDER |
6 |
0.0037 |
| 189 |
PROTEIN TOTAL DECREASED |
14 |
0.0037 |
| 190 |
WHITE BLOOD CELL COUNT INCREASED |
142 |
0.0037 |
| 191 |
BLEPHAROSPASM |
23 |
0.0036 |
| 192 |
PERIORBITAL HAEMATOMA |
3 |
0.0036 |
| 193 |
ONYCHOMADESIS |
15 |
0.0036 |
| 194 |
COLITIS ULCERATIVE |
159 |
0.0036 |
| 195 |
EXCESSIVE SKIN |
1 |
0.0035 |
| 196 |
ULCER HAEMORRHAGE |
24 |
0.0035 |
| 197 |
INFUSION RELATED REACTION |
233 |
0.0035 |
| 198 |
OEDEMA |
188 |
0.0035 |
| 199 |
PREMATURE AGEING |
1 |
0.0034 |
| 200 |
ILL-DEFINED DISORDER |
206 |
0.0034 |
| 201 |
CATHETER SITE HAEMATOMA |
1 |
0.0034 |
| 202 |
LABORATORY TEST ABNORMAL |
99 |
0.0034 |
| 203 |
FROSTBITE |
1 |
0.0033 |
| 204 |
CONTRAINDICATED PRODUCT ADMINISTERED |
101 |
0.0033 |
| 205 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
57 |
0.0033 |
| 206 |
EAR INFECTION FUNGAL |
1 |
0.0033 |
| 207 |
WHEEZING |
196 |
0.0033 |
| 208 |
MOBILITY DECREASED |
233 |
0.0032 |
| 209 |
JOINT STIFFNESS |
85 |
0.0032 |
| 210 |
DEVICE PROGRAMMING ERROR |
1 |
0.0032 |
| 211 |
FACIAL ASYMMETRY |
3 |
0.0031 |
| 212 |
COLD-STIMULUS HEADACHE |
1 |
0.0031 |
| 213 |
SKIN TEXTURE ABNORMAL |
3 |
0.0031 |
| 214 |
FOREIGN BODY IN EYE |
3 |
0.0031 |
| 215 |
IATROGENIC INJURY |
4 |
0.0031 |
| 216 |
C-REACTIVE PROTEIN INCREASED |
112 |
0.0031 |
| 217 |
CELLULITE |
1 |
0.0031 |
| 218 |
PSEUDOSTROKE |
1 |
0.0029 |
| 219 |
DEATH NEONATAL |
4 |
0.0029 |
| 220 |
OSTEOPOROSIS |
118 |
0.0029 |
| 221 |
OVERLAP SYNDROME |
2 |
0.0029 |
| 222 |
INJURY |
201 |
0.0029 |
| 223 |
DRY MOUTH |
231 |
0.0028 |
| 224 |
CONTUSION |
271 |
0.0028 |
| 225 |
HYPERNATRAEMIA |
14 |
0.0028 |
| 226 |
INDURATION |
5 |
0.0028 |
| 227 |
ABSCESS BACTERIAL |
1 |
0.0028 |
| 228 |
SYPHILIS |
2 |
0.0028 |
| 229 |
ATROPHIC VULVOVAGINITIS |
2 |
0.0027 |
| 230 |
LIVIDITY |
1 |
0.0027 |
| 231 |
MATERNAL EXPOSURE DURING PREGNANCY |
241 |
0.0027 |
| 232 |
SWELLING |
251 |
0.0027 |
| 233 |
POLYARTHRITIS |
14 |
0.0027 |
| 234 |
PANCREATITIS |
139 |
0.0026 |
| 235 |
LIPID METABOLISM DISORDER |
1 |
0.0026 |
| 236 |
PRESCRIBED UNDERDOSE |
52 |
0.0026 |
| 237 |
GASTROINTESTINAL DISORDER |
232 |
0.0026 |
| 238 |
CONVULSIVE THRESHOLD LOWERED |
1 |
0.0025 |
| 239 |
LIPOEDEMA |
1 |
0.0025 |
| 240 |
MUSCULOSKELETAL STIFFNESS |
223 |
0.0025 |
| 241 |
CATHETER SITE EXTRAVASATION |
1 |
0.0025 |
| 242 |
SINUSITIS |
254 |
0.0025 |
| 243 |
IIIRD NERVE PARALYSIS |
2 |
0.0025 |
| 244 |
ELECTROCARDIOGRAM ST SEGMENT ELEVATION |
8 |
0.0024 |
| 245 |
AMNESIA |
156 |
0.0024 |
| 246 |
ASTHMA |
270 |
0.0024 |
| 247 |
AMAUROSIS |
2 |
0.0024 |
| 248 |
EXPOSURE VIA EYE CONTACT |
1 |
0.0024 |
| 249 |
DRUG TOLERANCE |
12 |
0.0024 |
| 250 |
PSEUDOMONAL BACTERAEMIA |
2 |
0.0023 |
| 251 |
TISSUE INJURY |
1 |
0.0023 |
| 252 |
INTERCEPTED DRUG ADMINISTRATION ERROR |
1 |
0.0023 |
| 253 |
EXTRADURAL HAEMATOMA |
3 |
0.0023 |
| 254 |
GENERAL ANAESTHESIA |
1 |
0.0022 |
| 255 |
SKIN WRINKLING |
6 |
0.0022 |
| 256 |
IMMUNOGLOBULINS DECREASED |
3 |
0.0022 |
| 257 |
EXTRAOCULAR MUSCLE PARESIS |
1 |
0.0022 |
| 258 |
VITREOUS HAEMORRHAGE |
6 |
0.0022 |
| 259 |
EATING DISORDER SYMPTOM |
1 |
0.0022 |
| 260 |
FEELING HOT |
131 |
0.0021 |
| 261 |
SKIN INDENTATION |
1 |
0.0021 |
| 262 |
SENSORY LOSS |
17 |
0.0021 |
| 263 |
BLOOD ELECTROLYTES DECREASED |
3 |
0.0021 |
| 264 |
BLOOD CHOLESTEROL |
1 |
0.0021 |
| 265 |
LIPOATROPHY |
2 |
0.0021 |
| 266 |
NAIL INFECTION |
3 |
0.0021 |
| 267 |
VITREOUS DISORDER |
1 |
0.0021 |
| 268 |
RHEUMATOID ARTHRITIS |
235 |
0.0021 |
| 269 |
NAIL DISORDER |
18 |
0.0021 |
| 270 |
GENERAL PHYSICAL HEALTH DETERIORATION |
234 |
0.0020 |
| 271 |
EAR PAIN |
39 |
0.0020 |
| 272 |
URINARY TRACT PAIN |
1 |
0.0020 |
| 273 |
THERAPY NON-RESPONDER |
89 |
0.0020 |
| 274 |
SPINAL FUSION SURGERY |
8 |
0.0020 |
| 275 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
87 |
0.0019 |
| 276 |
SPONDYLITIS |
7 |
0.0019 |
| 277 |
ARTHRITIS |
151 |
0.0019 |
| 278 |
ABDOMINAL INJURY |
1 |
0.0019 |
| 279 |
IRIDOCYCLITIS |
6 |
0.0019 |
| 280 |
VASCULAR OCCLUSION |
4 |
0.0019 |
| 281 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
5 |
0.0019 |
| 282 |
PROTEIN TOTAL INCREASED |
5 |
0.0019 |
| 283 |
PERIORBITAL CELLULITIS |
1 |
0.0019 |
| 284 |
BLOOD IMMUNOGLOBULIN A INCREASED |
1 |
0.0019 |
| 285 |
JOINT SWELLING |
220 |
0.0018 |
| 286 |
GINGIVAL SWELLING |
8 |
0.0018 |
| 287 |
QUADRIPARESIS |
3 |
0.0018 |
| 288 |
SOFT TISSUE DISORDER |
2 |
0.0018 |
| 289 |
ABDOMINAL DISCOMFORT |
298 |
0.0018 |
| 290 |
APNOEIC ATTACK |
1 |
0.0018 |
| 291 |
PUSTULAR PSORIASIS |
6 |
0.0017 |
| 292 |
COLLAGEN DISORDER |
1 |
0.0017 |
| 293 |
HYPOAESTHESIA |
252 |
0.0017 |
| 294 |
LYMPHATIC DISORDER |
1 |
0.0017 |
| 295 |
BACK INJURY |
18 |
0.0017 |
| 296 |
PUPILLARY DISORDER |
1 |
0.0016 |
| 297 |
SLEEP DISORDER |
114 |
0.0016 |
| 298 |
CONFUSIONAL STATE |
260 |
0.0016 |
| 299 |
CONJUNCTIVAL HAEMORRHAGE |
6 |
0.0016 |
| 300 |
SKIN ATROPHY |
9 |
0.0016 |
| 301 |
GINGIVAL RECESSION |
3 |
0.0016 |
| 302 |
INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE |
1 |
0.0016 |
| 303 |
HYPOALBUMINAEMIA |
12 |
0.0015 |
| 304 |
VASCULAR DEVICE INFECTION |
7 |
0.0015 |
| 305 |
INFECTION |
223 |
0.0015 |
| 306 |
MUSCULAR WEAKNESS |
174 |
0.0015 |
| 307 |
BROW PTOSIS |
1 |
0.0015 |
| 308 |
HYPERSENSITIVITY |
278 |
0.0015 |
| 309 |
ALOPECIA |
294 |
0.0015 |
| 310 |
EYE MOVEMENT DISORDER |
10 |
0.0015 |
| 311 |
SURGICAL PROCEDURE REPEATED |
1 |
0.0015 |
| 312 |
DRUG INTOLERANCE |
140 |
0.0014 |
| 313 |
FUNCTIONAL GASTROINTESTINAL DISORDER |
5 |
0.0014 |
| 314 |
MIGRAINE |
137 |
0.0014 |
| 315 |
INTRAOCULAR PRESSURE TEST ABNORMAL |
1 |
0.0014 |
| 316 |
FACIAL DISCOMFORT |
1 |
0.0014 |
| 317 |
EYE ROLLING |
1 |
0.0014 |
| 318 |
CONNECTIVE TISSUE DISORDER |
2 |
0.0014 |
| 319 |
SYSTEMIC SCLERODERMA |
1 |
0.0014 |
| 320 |
SYMPTOM MASKED |
1 |
0.0014 |
| 321 |
DYSPEPSIA |
135 |
0.0014 |
| 322 |
LIP EROSION |
1 |
0.0014 |
| 323 |
BLOOD PHOSPHORUS DECREASED |
5 |
0.0014 |
| 324 |
NEUTROPHIL COUNT INCREASED |
14 |
0.0014 |
| 325 |
RETINAL VASCULAR OCCLUSION |
1 |
0.0014 |
| 326 |
PERIPHERAL SWELLING |
208 |
0.0013 |
| 327 |
CORNEAL DEPOSITS |
1 |
0.0013 |
| 328 |
SERRATIA INFECTION |
1 |
0.0013 |
| 329 |
URTICARIA |
225 |
0.0013 |
| 330 |
BRAIN STEM SYNDROME |
1 |
0.0013 |
| 331 |
INTRAOCULAR PRESSURE INCREASED |
17 |
0.0013 |
| 332 |
PAPILLOEDEMA |
6 |
0.0013 |
| 333 |
ADRENAL INSUFFICIENCY |
16 |
0.0013 |
| 334 |
HYPERTENSION |
279 |
0.0013 |
| 335 |
PARAINFLUENZAE VIRUS INFECTION |
2 |
0.0013 |
| 336 |
CHEST PAIN |
243 |
0.0013 |
| 337 |
TREATMENT FAILURE |
108 |
0.0013 |
| 338 |
RECTAL CANCER |
4 |
0.0013 |
| 339 |
LYMPHOEDEMA |
9 |
0.0013 |
| 340 |
EYELID DISORDER |
3 |
0.0013 |
| 341 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
62 |
0.0013 |
| 342 |
NORMAL NEWBORN |
7 |
0.0013 |
| 343 |
CORNEAL TRANSPLANT |
1 |
0.0013 |
| 344 |
PARAESTHESIA |
201 |
0.0013 |
| 345 |
IMMUNODEFICIENCY |
19 |
0.0013 |
| 346 |
CROUP INFECTIOUS |
1 |
0.0013 |
| 347 |
TINEA PEDIS |
2 |
0.0013 |
| 348 |
PERFORATION |
1 |
0.0012 |
| 349 |
NASOPHARYNGITIS |
228 |
0.0012 |
| 350 |
STRESS CARDIOMYOPATHY |
7 |
0.0012 |
| 351 |
ABDOMINAL PAIN UPPER |
245 |
0.0012 |
| 352 |
PERIORBITAL PAIN |
1 |
0.0012 |
| 353 |
OEDEMA PERIPHERAL |
142 |
0.0012 |
| 354 |
INTENTIONAL PRODUCT USE ISSUE |
101 |
0.0012 |
| 355 |
HYPERTRANSAMINASAEMIA |
8 |
0.0011 |
| 356 |
MUSCLE SPASMS |
211 |
0.0011 |
| 357 |
MEMORY IMPAIRMENT |
157 |
0.0011 |
| 358 |
ONYCHOMYCOSIS |
5 |
0.0011 |
| 359 |
DECREASED APPETITE |
260 |
0.0011 |
| 360 |
ORAL FUNGAL INFECTION |
3 |
0.0011 |
| 361 |
TYPE IV HYPERSENSITIVITY REACTION |
3 |
0.0011 |
| 362 |
CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN |
1 |
0.0011 |
| 363 |
PSYCHOMOTOR RETARDATION |
3 |
0.0011 |
| 364 |
WEIGHT INCREASED |
237 |
0.0011 |
| 365 |
MYELOPATHY |
2 |
0.0011 |
| 366 |
VISUAL IMPAIRMENT |
129 |
0.0010 |
| 367 |
TELANGIECTASIA |
1 |
0.0010 |
| 368 |
TASTE DISORDER |
21 |
0.0010 |
| 369 |
EYELID OEDEMA |
12 |
0.0010 |
| 370 |
FINGER DEFORMITY |
5 |
0.0010 |
| 371 |
PRODUCT LABEL CONFUSION |
6 |
0.0010 |
| 372 |
JOINT NOISE |
2 |
0.0010 |
| 373 |
MEDICATION ERROR |
56 |
0.0010 |
| 374 |
ADMINISTRATION SITE EXTRAVASATION |
1 |
0.0010 |
| 375 |
SKIN OEDEMA |
1 |
0.0010 |
| 376 |
SENSORY DISTURBANCE |
16 |
0.0010 |
| 377 |
HYPOPHYSITIS |
2 |
0.0010 |
| 378 |
LYMPHOPENIA |
14 |
0.0010 |
| 379 |
REDUCED FACIAL EXPRESSION |
1 |
0.0010 |
| 380 |
AKINESIA |
2 |
0.0010 |
| 381 |
EJECTION FRACTION DECREASED |
15 |
0.0010 |
| 382 |
PERIORBITAL OEDEMA |
5 |
0.0010 |
| 383 |
GASTROINTESTINAL VIRAL INFECTION |
1 |
0.0010 |
| 384 |
SINUSITIS BACTERIAL |
1 |
0.0009 |
| 385 |
EXPOSURE DURING PREGNANCY |
59 |
0.0009 |
| 386 |
INNER EAR DISORDER |
1 |
0.0009 |
| 387 |
SUBRETINAL FLUID |
1 |
0.0009 |
| 388 |
ADVERSE EVENT |
84 |
0.0009 |
| 389 |
DISABILITY |
18 |
0.0009 |
| 390 |
SKIN INJURY |
3 |
0.0009 |
| 391 |
CORNEAL OEDEMA |
2 |
0.0009 |
| 392 |
MYOCARDIAL INJURY |
1 |
0.0009 |
| 393 |
EYELID PTOSIS |
9 |
0.0009 |
| 394 |
ANXIETY |
252 |
0.0009 |
| 395 |
HALO VISION |
1 |
0.0009 |
| 396 |
LIVER FUNCTION TEST INCREASED |
19 |
0.0009 |
| 397 |
MOANING |
1 |
0.0009 |
| 398 |
PUPILS UNEQUAL |
1 |
0.0009 |
| 399 |
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE |
16 |
0.0009 |
| 400 |
RETINAL DETACHMENT |
8 |
0.0009 |
| 401 |
OPTIC NERVE INJURY |
1 |
0.0009 |
| 402 |
DEFORMITY |
8 |
0.0009 |
| 403 |
RETINAL HAEMORRHAGE |
6 |
0.0008 |
| 404 |
BLOOD UREA INCREASED |
14 |
0.0008 |
| 405 |
RASH VESICULAR |
4 |
0.0008 |
| 406 |
CONDITION AGGRAVATED |
251 |
0.0008 |
| 407 |
BLOOD IMMUNOGLOBULIN G INCREASED |
1 |
0.0008 |
| 408 |
COELIAC DISEASE |
8 |
0.0008 |
| 409 |
POST-ACUTE COVID-19 SYNDROME |
1 |
0.0008 |
| 410 |
ALLERGY TO CHEMICALS |
1 |
0.0008 |
| 411 |
INFUSION SITE SWELLING |
5 |
0.0008 |
| 412 |
POST PROCEDURAL COMPLICATION |
15 |
0.0008 |
| 413 |
MYOSITIS |
7 |
0.0008 |
| 414 |
RETINAL DEGENERATION |
1 |
0.0008 |
| 415 |
EPIGASTRIC DISCOMFORT |
3 |
0.0008 |
| 416 |
COUNTERFEIT PRODUCT ADMINISTERED |
1 |
0.0008 |
| 417 |
LIP INJURY |
1 |
0.0008 |
| 418 |
VISUAL ACUITY REDUCED |
25 |
0.0008 |
| 419 |
INSOMNIA |
200 |
0.0008 |
| 420 |
PLASMA CELL MYELOMA REFRACTORY |
1 |
0.0007 |
| 421 |
ASTHENIA |
281 |
0.0007 |
| 422 |
DEPRESSION |
170 |
0.0007 |
| 423 |
MUSCLE TWITCHING |
17 |
0.0007 |
| 424 |
SKIN DEPIGMENTATION |
1 |
0.0007 |
| 425 |
ISCHAEMIC HEPATITIS |
1 |
0.0007 |
| 426 |
ASPIRATION |
8 |
0.0007 |
| 427 |
ADVERSE DRUG REACTION |
65 |
0.0007 |
| 428 |
EPILEPSY |
22 |
0.0007 |
| 429 |
PYREXIA |
246 |
0.0007 |
| 430 |
ATYPICAL MYCOBACTERIAL INFECTION |
1 |
0.0007 |
| 431 |
MYDRIASIS |
9 |
0.0007 |
| 432 |
VASCULAR INJURY |
1 |
0.0007 |
| 433 |
GAIT DISTURBANCE |
132 |
0.0007 |
| 434 |
ADENOVIRUS INFECTION |
2 |
0.0007 |
| 435 |
PRODUCT USE ISSUE |
128 |
0.0007 |
| 436 |
KNEE DEFORMITY |
1 |
0.0007 |
| 437 |
ARTHRALGIA |
280 |
0.0007 |
| 438 |
SKIN STRIAE |
1 |
0.0007 |
| 439 |
HYPOKALAEMIA |
31 |
0.0007 |
| 440 |
BLOOD BILIRUBIN INCREASED |
18 |
0.0007 |
| 441 |
ASTIGMATISM |
1 |
0.0007 |
| 442 |
MOUTH INJURY |
1 |
0.0007 |
| 443 |
WEIGHT DECREASED |
184 |
0.0007 |
| 444 |
IRITIS |
2 |
0.0007 |
| 445 |
KERATITIS |
2 |
0.0007 |
| 446 |
ASCITES |
19 |
0.0006 |
| 447 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
16 |
0.0006 |
| 448 |
APNOEA |
5 |
0.0006 |
| 449 |
TRANSCRIPTION MEDICATION ERROR |
1 |
0.0006 |
| 450 |
DRUG-INDUCED LIVER INJURY |
20 |
0.0006 |
| 451 |
MUSCLE ATROPHY |
8 |
0.0006 |
| 452 |
PHARYNGEAL PARAESTHESIA |
1 |
0.0006 |
| 453 |
NECK PAIN |
35 |
0.0006 |
| 454 |
PRURITUS |
235 |
0.0006 |
| 455 |
INFUSION SITE HAEMORRHAGE |
2 |
0.0006 |
| 456 |
INJECTION RELATED REACTION |
1 |
0.0006 |
| 457 |
UPPER RESPIRATORY TRACT INFECTION |
28 |
0.0006 |
| 458 |
GENERALISED TONIC-CLONIC SEIZURE |
10 |
0.0006 |
| 459 |
INTERCEPTED PRODUCT DISPENSING ERROR |
1 |
0.0006 |
| 460 |
OSTEOPENIA |
9 |
0.0006 |
| 461 |
FACIAL PARALYSIS |
5 |
0.0006 |
| 462 |
PUPIL FIXED |
1 |
0.0006 |
| 463 |
SPINAL CORD INJURY |
1 |
0.0006 |
| 464 |
MUSCLE SPASTICITY |
7 |
0.0006 |
| 465 |
DRUG ADMINISTERED AT INAPPROPRIATE SITE |
6 |
0.0006 |
| 466 |
MACULOPATHY |
2 |
0.0006 |
| 467 |
DRUG MONITORING PROCEDURE NOT PERFORMED |
1 |
0.0006 |
| 468 |
MALAISE |
242 |
0.0006 |
| 469 |
UNDERDOSE |
40 |
0.0005 |
| 470 |
PUPILLARY REFLEX IMPAIRED |
1 |
0.0005 |
| 471 |
GRANULOCYTE COUNT DECREASED |
1 |
0.0005 |
| 472 |
VOMITING |
253 |
0.0005 |
| 473 |
LYMPH NODE PAIN |
1 |
0.0005 |
| 474 |
GENERAL SYMPTOM |
4 |
0.0005 |
| 475 |
PERIORBITAL SWELLING |
3 |
0.0005 |
| 476 |
LIP DISORDER |
1 |
0.0005 |
| 477 |
PANCREATIC CYST |
1 |
0.0005 |
| 478 |
DIZZINESS |
261 |
0.0005 |
| 479 |
DEVICE RELATED INFECTION |
8 |
0.0005 |
| 480 |
ATROPHY |
1 |
0.0005 |
| 481 |
RASH |
224 |
0.0005 |
| 482 |
CEREBRAL HAEMORRHAGE |
18 |
0.0005 |
| 483 |
ABDOMINAL PAIN |
116 |
0.0005 |
| 484 |
SMALL INTESTINAL HAEMORRHAGE |
1 |
0.0005 |
| 485 |
FUNGAL SKIN INFECTION |
2 |
0.0005 |
| 486 |
EYELID PAIN |
1 |
0.0005 |
| 487 |
BACK DISORDER |
8 |
0.0005 |
| 488 |
IMMUNE-MEDIATED HEPATITIS |
1 |
0.0005 |
| 489 |
EXTRAVASATION |
2 |
0.0005 |
| 490 |
VENOUS THROMBOSIS LIMB |
1 |
0.0005 |
| 491 |
PNEUMONIA |
153 |
0.0005 |
| 492 |
DYSPNOEA |
267 |
0.0005 |
| 493 |
CRYING |
17 |
0.0005 |
| 494 |
INFUSION SITE BRUISING |
1 |
0.0005 |
| 495 |
INJECTION SITE INDENTATION |
1 |
0.0005 |
| 496 |
ELECTROCARDIOGRAM ST SEGMENT DEPRESSION |
1 |
0.0005 |
| 497 |
INFECTIOUS MONONUCLEOSIS |
1 |
0.0004 |
| 498 |
HEADACHE |
279 |
0.0004 |
| 499 |
RASH PRURITIC |
24 |
0.0004 |
| 500 |
SUSPECTED OFF LABEL USE |
2 |
0.0004 |
| 501 |
DIARRHOEA |
282 |
0.0004 |
| 502 |
RED BLOOD CELL SEDIMENTATION RATE ABNORMAL |
1 |
0.0004 |
| 503 |
ROSACEA |
2 |
0.0004 |
| 504 |
SKIN TIGHTNESS |
2 |
0.0004 |
| 505 |
INGROWING NAIL |
1 |
0.0004 |
| 506 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
30 |
0.0004 |
| 507 |
URINE FLOW DECREASED |
1 |
0.0004 |
| 508 |
SUPRAVENTRICULAR TACHYCARDIA |
4 |
0.0004 |
| 509 |
VISUAL FIELD DEFECT |
3 |
0.0004 |
| 510 |
BLOOD IMMUNOGLOBULIN E INCREASED |
1 |
0.0004 |
| 511 |
EYE OEDEMA |
1 |
0.0004 |
| 512 |
BODY TEMPERATURE DECREASED |
4 |
0.0004 |
| 513 |
RETINAL TEAR |
1 |
0.0004 |
| 514 |
DEVICE INFUSION ISSUE |
1 |
0.0004 |
| 515 |
TACHYCARDIA |
35 |
0.0004 |
| 516 |
FATIGUE |
305 |
0.0004 |
| 517 |
PAIN IN EXTREMITY |
115 |
0.0004 |
| 518 |
PHYSICAL DECONDITIONING |
1 |
0.0004 |
| 519 |
DIPLOPIA |
10 |
0.0004 |
| 520 |
POSTMENOPAUSAL HAEMORRHAGE |
1 |
0.0004 |
| 521 |
BRAIN FOG |
6 |
0.0004 |
| 522 |
AGITATION |
28 |
0.0004 |
| 523 |
DEPRESSED MOOD |
20 |
0.0004 |
| 524 |
GASTROOESOPHAGEAL REFLUX DISEASE |
30 |
0.0004 |
| 525 |
PRODUCT USE IN UNAPPROVED INDICATION |
91 |
0.0004 |
| 526 |
PAIN |
224 |
0.0004 |
| 527 |
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN |
1 |
0.0004 |
| 528 |
EOSINOPHILIC OESOPHAGITIS |
1 |
0.0004 |
| 529 |
NERVE INJURY |
4 |
0.0004 |
| 530 |
HAEMORRHOIDS |
7 |
0.0004 |
| 531 |
SKIN HYPERTROPHY |
1 |
0.0004 |
| 532 |
INFUSION SITE ERYTHEMA |
3 |
0.0004 |
| 533 |
REBOUND EFFECT |
4 |
0.0004 |
| 534 |
EYE SWELLING |
13 |
0.0003 |
| 535 |
EXERCISE TOLERANCE DECREASED |
2 |
0.0003 |
| 536 |
LUNG CANCER METASTATIC |
1 |
0.0003 |
| 537 |
MUSCLE STRAIN |
3 |
0.0003 |
| 538 |
PARAPLEGIA |
1 |
0.0003 |
| 539 |
BODY TEMPERATURE INCREASED |
7 |
0.0003 |
| 540 |
FACIAL PAIN |
3 |
0.0003 |
| 541 |
ENDOPHTHALMITIS |
2 |
0.0003 |
| 542 |
METABOLIC ENCEPHALOPATHY |
1 |
0.0003 |
| 543 |
BONE MARROW DISORDER |
1 |
0.0003 |
| 544 |
INJECTION SITE VESICLES |
2 |
0.0003 |
| 545 |
PRESYNCOPE |
8 |
0.0003 |
| 546 |
MENISCUS INJURY |
2 |
0.0003 |
| 547 |
MULTIPLE-DRUG RESISTANCE |
1 |
0.0003 |
| 548 |
INFUSION SITE EXTRAVASATION |
2 |
0.0003 |
| 549 |
THERAPY PARTIAL RESPONDER |
5 |
0.0003 |
| 550 |
ASPARTATE AMINOTRANSFERASE INCREASED |
17 |
0.0003 |
| 551 |
EYE INFLAMMATION |
3 |
0.0003 |
| 552 |
WHITE BLOOD CELL COUNT ABNORMAL |
2 |
0.0003 |
| 553 |
CUSHINGOID |
1 |
0.0003 |
| 554 |
HYPOVENTILATION |
1 |
0.0003 |
| 555 |
MUCOSAL INFLAMMATION |
8 |
0.0003 |
| 556 |
SKIN MASS |
2 |
0.0003 |
| 557 |
BRAIN INJURY |
3 |
0.0003 |
| 558 |
SCAR |
5 |
0.0003 |
| 559 |
APLASIA PURE RED CELL |
1 |
0.0003 |
| 560 |
VIITH NERVE PARALYSIS |
1 |
0.0003 |
| 561 |
GRANULOMA |
1 |
0.0003 |
| 562 |
MASS |
4 |
0.0003 |
| 563 |
BRONCHIOLITIS |
1 |
0.0003 |
| 564 |
TYPE I HYPERSENSITIVITY |
1 |
0.0003 |
| 565 |
OSTEONECROSIS OF JAW |
7 |
0.0003 |
| 566 |
IRRITABILITY |
17 |
0.0003 |
| 567 |
FACIAL PARESIS |
1 |
0.0003 |
| 568 |
CHRONIC GRAFT VERSUS HOST DISEASE |
1 |
0.0003 |
| 569 |
HYPERACUSIS |
1 |
0.0003 |
| 570 |
RETINOPATHY |
1 |
0.0003 |
| 571 |
PARANASAL SINUS DISCOMFORT |
1 |
0.0003 |
| 572 |
PRODUCT STORAGE ISSUE |
1 |
0.0003 |
| 573 |
THERAPEUTIC RESPONSE DECREASED |
16 |
0.0003 |
| 574 |
FACE INJURY |
1 |
0.0003 |
| 575 |
OFF LABEL USE |
230 |
0.0003 |
| 576 |
PROCEDURAL COMPLICATION |
2 |
0.0003 |
| 577 |
ALANINE AMINOTRANSFERASE INCREASED |
16 |
0.0003 |
| 578 |
FOETAL EXPOSURE DURING PREGNANCY |
21 |
0.0003 |
| 579 |
WOUND SECRETION |
1 |
0.0003 |
| 580 |
TRIGEMINAL NEURALGIA |
1 |
0.0002 |
| 581 |
ORGAN FAILURE |
1 |
0.0002 |
| 582 |
EYE PAIN |
14 |
0.0002 |
| 583 |
MUSCLE DISORDER |
2 |
0.0002 |
| 584 |
MATERNAL EXPOSURE DURING BREAST FEEDING |
1 |
0.0002 |
| 585 |
ACCIDENTAL OVERDOSE |
9 |
0.0002 |
| 586 |
BLOOD CREATININE INCREASED |
16 |
0.0002 |
| 587 |
RESPIRATORY DEPRESSION |
3 |
0.0002 |
| 588 |
PHOTOSENSITIVITY REACTION |
4 |
0.0002 |
| 589 |
SUICIDAL BEHAVIOUR |
1 |
0.0002 |
| 590 |
LEUKOPENIA |
12 |
0.0002 |
| 591 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
13 |
0.0002 |
| 592 |
NAUSEA |
186 |
0.0002 |
| 593 |
INCORRECT DRUG ADMINISTRATION RATE |
1 |
0.0002 |
| 594 |
UTERINE HAEMORRHAGE |
1 |
0.0002 |
| 595 |
INFUSION SITE PAIN |
3 |
0.0002 |
| 596 |
NEOPLASM PROGRESSION |
8 |
0.0002 |
| 597 |
BLOOD CALCIUM INCREASED |
2 |
0.0002 |
| 598 |
GROIN PAIN |
2 |
0.0002 |
| 599 |
LOSS OF CONSCIOUSNESS |
29 |
0.0002 |
| 600 |
ADVERSE REACTION |
3 |
0.0002 |
| 601 |
HEAD DISCOMFORT |
4 |
0.0002 |
| 602 |
BLINDNESS |
9 |
0.0002 |
| 603 |
BLOOD PRESSURE SYSTOLIC DECREASED |
1 |
0.0002 |
| 604 |
BALANCE DISORDER |
19 |
0.0002 |
| 605 |
THERAPEUTIC PRODUCT EFFECT DELAYED |
1 |
0.0002 |
| 606 |
HAEMOGLOBIN INCREASED |
1 |
0.0002 |
| 607 |
EAR DISORDER |
1 |
0.0002 |
| 608 |
DRUG LEVEL ABOVE THERAPEUTIC |
1 |
0.0002 |
| 609 |
LOCALISED OEDEMA |
1 |
0.0002 |
| 610 |
SKIN REACTION |
3 |
0.0002 |
| 611 |
SKIN ABRASION |
1 |
0.0002 |
| 612 |
SKIN DISORDER |
7 |
0.0002 |
| 613 |
ENDOMETRIOSIS |
1 |
0.0002 |
| 614 |
IMPAIRED QUALITY OF LIFE |
3 |
0.0002 |
| 615 |
LIMB OPERATION |
1 |
0.0002 |
| 616 |
HUMERUS FRACTURE |
1 |
0.0002 |
| 617 |
THROMBOCYTOPENIA |
23 |
0.0002 |
| 618 |
INFLAMMATORY BOWEL DISEASE |
2 |
0.0002 |
| 619 |
ABDOMINAL TENDERNESS |
1 |
0.0002 |
| 620 |
TREATMENT NONCOMPLIANCE |
11 |
0.0002 |
| 621 |
DRY EYE |
10 |
0.0002 |
| 622 |
VEIN DISORDER |
1 |
0.0002 |
| 623 |
BURNING SENSATION |
14 |
0.0002 |
| 624 |
PSORIASIS |
26 |
0.0002 |
| 625 |
PRODUCT SOLUBILITY ABNORMAL |
1 |
0.0002 |
| 626 |
KLEBSIELLA INFECTION |
1 |
0.0002 |
| 627 |
AMMONIA INCREASED |
1 |
0.0002 |
| 628 |
HEPATITIS |
5 |
0.0002 |
| 629 |
PRODUCT TEMPERATURE EXCURSION ISSUE |
1 |
0.0002 |
| 630 |
VARICOSE VEIN |
1 |
0.0002 |
| 631 |
SKIN NECROSIS |
1 |
0.0002 |
| 632 |
BRONCHITIS |
14 |
0.0002 |
| 633 |
GINGIVITIS |
1 |
0.0002 |
| 634 |
ERYTHEMA OF EYELID |
1 |
0.0002 |
| 635 |
HOSPITALISATION |
28 |
0.0002 |
| 636 |
ASTHENOPIA |
1 |
0.0002 |
| 637 |
INTESTINAL ISCHAEMIA |
1 |
0.0002 |
| 638 |
INJECTION SITE INJURY |
1 |
0.0002 |
| 639 |
ANGIOPATHY |
1 |
0.0002 |
| 640 |
MACULAR OEDEMA |
1 |
0.0002 |
| 641 |
OCULAR DISCOMFORT |
2 |
0.0002 |
| 642 |
OXYGEN SATURATION DECREASED |
10 |
0.0002 |
| 643 |
PERONEAL NERVE PALSY |
1 |
0.0002 |
| 644 |
VISUAL DISTURBANCE |
1 |
0.0002 |
| 645 |
SKIN DISCOLOURATION |
8 |
0.0002 |
| 646 |
HYPOVOLAEMIA |
1 |
0.0002 |
| 647 |
FEELING OF BODY TEMPERATURE CHANGE |
1 |
0.0002 |
| 648 |
GLUCOSE TOLERANCE IMPAIRED |
1 |
0.0002 |
| 649 |
CATARACT OPERATION |
1 |
0.0002 |
| 650 |
MYOCLONUS |
2 |
0.0002 |
| 651 |
INJECTION SITE EXTRAVASATION |
2 |
0.0002 |
| 652 |
PIGMENTATION DISORDER |
1 |
0.0002 |
| 653 |
PHARYNGITIS |
2 |
0.0002 |
| 654 |
NASAL DRYNESS |
1 |
0.0002 |
| 655 |
PHOTOPHOBIA |
3 |
0.0002 |
| 656 |
BLOOD SODIUM DECREASED |
3 |
0.0002 |
| 657 |
MULTIPLE INJURIES |
1 |
0.0002 |
| 658 |
SWELLING FACE |
10 |
0.0002 |
| 659 |
NODULE |
2 |
0.0002 |
| 660 |
SEDATION |
4 |
0.0002 |
| 661 |
PRODUCT PREPARATION ISSUE |
1 |
0.0002 |
| 662 |
IMMUNE SYSTEM DISORDER |
2 |
0.0002 |
| 663 |
SARS-COV-2 TEST POSITIVE |
2 |
0.0002 |
| 664 |
COLITIS ISCHAEMIC |
1 |
0.0001 |
| 665 |
PLEURAL EFFUSION |
9 |
0.0001 |
| 666 |
PALLOR |
4 |
0.0001 |
| 667 |
DRUG TOXICITY |
2 |
0.0001 |
| 668 |
BACK PAIN |
34 |
0.0001 |
| 669 |
CROHN'S DISEASE |
1 |
0.0001 |
| 670 |
ECCHYMOSIS |
1 |
0.0001 |
| 671 |
ENCEPHALITIS |
1 |
0.0001 |
| 672 |
LARGE INTESTINE PERFORATION |
1 |
0.0001 |
| 673 |
ORAL DISCOMFORT |
2 |
0.0001 |
| 674 |
APHONIA |
2 |
0.0001 |
| 675 |
DUODENAL ULCER |
1 |
0.0001 |
| 676 |
SEASONAL ALLERGY |
2 |
0.0001 |
| 677 |
DIVERTICULUM |
1 |
0.0001 |
| 678 |
FEAR OF INJECTION |
1 |
0.0001 |
| 679 |
BRONCHOSPASM |
2 |
0.0001 |
| 680 |
CARDIOGENIC SHOCK |
2 |
0.0001 |
| 681 |
RASH PUSTULAR |
1 |
0.0001 |
| 682 |
HAEMOGLOBIN DECREASED |
14 |
0.0001 |
| 683 |
MEDICAL DEVICE COMPLICATION |
1 |
0.0001 |
| 684 |
CEREBRAL DISORDER |
1 |
0.0001 |
| 685 |
HYPOAESTHESIA ORAL |
2 |
0.0001 |
| 686 |
TROPONIN INCREASED |
1 |
0.0001 |
| 687 |
ACIDOSIS |
1 |
0.0001 |
| 688 |
INTERCEPTED PRODUCT ADMINISTRATION ERROR |
1 |
0.0001 |
| 689 |
MUSCULOSKELETAL CHEST PAIN |
2 |
0.0001 |
| 690 |
TENDONITIS |
2 |
0.0001 |
| 691 |
BRONCHOPULMONARY ASPERGILLOSIS |
1 |
0.0001 |
| 692 |
CONSTIPATION |
28 |
0.0001 |
| 693 |
DRUG INEFFECTIVE |
169 |
0.0001 |
| 694 |
HAEMORRHAGIC STROKE |
1 |
0.0001 |
| 695 |
MULTIPLE ALLERGIES |
1 |
0.0001 |
| 696 |
PRODUCT QUALITY ISSUE |
17 |
0.0001 |
| 697 |
NEURALGIA |
3 |
0.0001 |
| 698 |
ESCHERICHIA INFECTION |
1 |
0.0001 |
| 699 |
HEMIPLEGIA |
1 |
0.0001 |
| 700 |
HOT FLUSH |
9 |
0.0001 |
| 701 |
CELLULITIS |
6 |
0.0001 |
| 702 |
CANDIDA INFECTION |
2 |
0.0001 |
| 703 |
SKIN HYPERPIGMENTATION |
1 |
0.0001 |
| 704 |
INJECTION SITE REACTION |
8 |
0.0001 |
| 705 |
NEUROPATHY PERIPHERAL |
11 |
0.0001 |
| 706 |
PHARMACEUTICAL PRODUCT COMPLAINT |
3 |
0.0001 |
| 707 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
1 |
0.0001 |
| 708 |
TREMOR |
19 |
0.0001 |
| 709 |
ANGIOEDEMA |
5 |
0.0001 |
| 710 |
WRONG DRUG ADMINISTERED |
1 |
0.0001 |
| 711 |
OPTIC NEURITIS |
1 |
0.0001 |
| 712 |
PNEUMONIA BACTERIAL |
1 |
0.0001 |
| 713 |
NERVE COMPRESSION |
1 |
0.0001 |
| 714 |
GRAND MAL CONVULSION |
1 |
0.0001 |
| 715 |
BREAST CANCER STAGE I |
1 |
0.0001 |
| 716 |
ERYTHEMA MULTIFORME |
1 |
0.0001 |
| 717 |
EPISTAXIS |
8 |
0.0001 |
| 718 |
PAIN IN JAW |
3 |
0.0001 |
| 719 |
ACUTE RESPIRATORY FAILURE |
2 |
0.0001 |
| 720 |
SINUS DISORDER |
2 |
0.0001 |
| 721 |
BLADDER DISORDER |
1 |
0.0001 |
| 722 |
HYPOTONIA |
1 |
0.0001 |
| 723 |
URINARY TRACT INFECTION |
17 |
0.0001 |
| 724 |
ANAEMIA |
19 |
0.0001 |
| 725 |
VAGINAL DISCHARGE |
1 |
0.0001 |
| 726 |
SEPSIS |
11 |
0.0001 |
| 727 |
FLUID RETENTION |
5 |
0.0001 |
| 728 |
SLUGGISHNESS |
1 |
0.0001 |
| 729 |
EAR DISCOMFORT |
1 |
0.0001 |
| 730 |
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION |
1 |
0.0001 |
| 731 |
INFLUENZA LIKE ILLNESS |
8 |
0.0001 |
| 732 |
POOR VENOUS ACCESS |
1 |
0.0001 |
| 733 |
EYE DISCHARGE |
1 |
0.0001 |
| 734 |
TENDERNESS |
1 |
0.0001 |
| 735 |
HAEMORRHAGE |
10 |
0.0001 |
| 736 |
INJECTION SITE DISCOMFORT |
1 |
0.0001 |
| 737 |
INCONTINENCE |
1 |
0.0001 |
| 738 |
SKIN LACERATION |
1 |
0.0001 |
| 739 |
SEPTIC SHOCK |
4 |
0.0001 |
| 740 |
PRODUCT DISPENSING ERROR |
2 |
0.0001 |
| 741 |
STAPHYLOCOCCAL INFECTION |
3 |
0.0001 |
| 742 |
OBSTRUCTIVE AIRWAYS DISORDER |
1 |
0.0001 |
| 743 |
SKIN INFECTION |
1 |
0.0001 |
| 744 |
MYOCARDIAL ISCHAEMIA |
1 |
0.0001 |
| 745 |
ERYTHEMA |
18 |
0.0001 |
| 746 |
NEOPLASM |
1 |
0.0001 |
| 747 |
UNINTENTIONAL MEDICAL DEVICE REMOVAL |
1 |
0.0001 |
| 748 |
ABDOMINAL DISTENSION |
9 |
0.0001 |
| 749 |
ARRHYTHMIA |
4 |
0.0001 |
| 750 |
ATAXIA |
1 |
0.0001 |
| 751 |
CHOLECYSTITIS |
1 |
0.0001 |
| 752 |
SKIN BURNING SENSATION |
6 |
0.0001 |
| 753 |
WHITE BLOOD CELL COUNT DECREASED |
9 |
0.0001 |
| 754 |
INJECTION SITE PAIN |
25 |
0.0001 |
| 755 |
GENERALISED OEDEMA |
1 |
0.0001 |
| 756 |
CYST |
1 |
0.0001 |
| 757 |
INJECTION SITE DISCOLOURATION |
1 |
0.0001 |
| 758 |
INTENTIONAL PRODUCT MISUSE |
7 |
0.0001 |
| 759 |
DYSARTHRIA |
3 |
0.0001 |
| 760 |
POISONING |
1 |
0.0001 |
| 761 |
METASTASES TO CENTRAL NERVOUS SYSTEM |
1 |
0.0001 |
| 762 |
UNRESPONSIVE TO STIMULI |
2 |
0.0001 |
| 763 |
HAEMATOMA |
2 |
0.0001 |
| 764 |
RESPIRATORY TRACT INFECTION |
2 |
0.0001 |
| 765 |
ORAL CANDIDIASIS |
1 |
0.0001 |
| 766 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
3 |
0.0001 |
| 767 |
QUALITY OF LIFE DECREASED |
1 |
0.0001 |
| 768 |
BLOOD GLUCOSE INCREASED |
14 |
0.0001 |
| 769 |
SINUS CONGESTION |
1 |
0.0001 |
| 770 |
DEVICE BREAKAGE |
3 |
0.0001 |
| 771 |
NEUTROPENIA |
10 |
0.0001 |
| 772 |
SKIN LESION |
2 |
0.0001 |
| 773 |
ANAPHYLACTIC REACTION |
4 |
0.0001 |
| 774 |
HAEMOPTYSIS |
2 |
0.0001 |
| 775 |
BLOOD TEST ABNORMAL |
1 |
0.0001 |
| 776 |
SINUS TACHYCARDIA |
1 |
0.0001 |
| 777 |
CONVULSION |
4 |
0.0001 |
| 778 |
ANOSMIA |
1 |
0.0001 |
| 779 |
DEVICE DISLOCATION |
3 |
0.0001 |
| 780 |
SKIN HAEMORRHAGE |
1 |
0.0001 |
| 781 |
DRY SKIN |
9 |
0.0001 |
| 782 |
VISION BLURRED |
9 |
0.0001 |
| 783 |
DRUG DISPENSING ERROR |
1 |
0.0001 |
| 784 |
INSURANCE ISSUE |
1 |
0.0001 |
| 785 |
TINNITUS |
3 |
0.0001 |
| 786 |
DEVICE ADHESION ISSUE |
1 |
0.0001 |
| 787 |
THYROID DISORDER |
1 |
0.0001 |
| 788 |
LIMB DISCOMFORT |
2 |
0.0001 |
| 789 |
NERVOUS SYSTEM DISORDER |
2 |
0.0001 |
| 790 |
OCULAR HYPERAEMIA |
3 |
0.0001 |
| 791 |
INJECTION SITE BRUISING |
5 |
0.0001 |
| 792 |
MUSCLE TIGHTNESS |
1 |
0.0001 |
| 793 |
DRUG LEVEL INCREASED |
1 |
0.0001 |
| 794 |
PSYCHOMOTOR HYPERACTIVITY |
1 |
0.0001 |
| 795 |
EXPIRED PRODUCT ADMINISTERED |
2 |
0.0001 |
| 796 |
VIRAL INFECTION |
2 |
0.0001 |
| 797 |
LIP SWELLING |
2 |
0.0001 |
| 798 |
CIRCULATORY COLLAPSE |
1 |
0.0001 |
| 799 |
NEUROTOXICITY |
1 |
0.0001 |
| 800 |
AMENORRHOEA |
1 |
0.0001 |
| 801 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
1 |
0.0001 |
| 802 |
THIRST |
1 |
0.0001 |
| 803 |
INCORRECT ROUTE OF DRUG ADMINISTRATION |
2 |
0.0001 |
| 804 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
10 |
0.0001 |
| 805 |
GASTROENTERITIS VIRAL |
1 |
0.0001 |
| 806 |
BONE DISORDER |
1 |
0.0001 |
| 807 |
PANIC ATTACK |
2 |
0.0001 |
| 808 |
CONJUNCTIVITIS |
1 |
0.0001 |
| 809 |
BACTERIAL INFECTION |
1 |
0.0001 |
| 810 |
DEATH |
46 |
0.0001 |
| 811 |
GASTRIC ULCER |
1 |
0.0001 |
| 812 |
MUSCULOSKELETAL DISORDER |
1 |
0.0001 |
| 813 |
FEELING JITTERY |
1 |
0.0001 |
| 814 |
INJECTION SITE SWELLING |
4 |
0.0001 |
| 815 |
GLAUCOMA |
1 |
0.0001 |
| 816 |
HERNIA |
1 |
0.0001 |
| 817 |
ORAL HERPES |
1 |
0.0001 |
| 818 |
CHILLS |
6 |
0.0001 |
| 819 |
HAEMATOCRIT DECREASED |
1 |
0.0001 |
| 820 |
UPPER LIMB FRACTURE |
1 |
0.0001 |
| 821 |
CYTOKINE RELEASE SYNDROME |
1 |
0.0000 |
| 822 |
PRODUCT ADMINISTRATION ERROR |
1 |
0.0000 |
| 823 |
DYSKINESIA |
2 |
0.0000 |
| 824 |
INJURY ASSOCIATED WITH DEVICE |
1 |
0.0000 |
| 825 |
NEUTROPHIL COUNT DECREASED |
2 |
0.0000 |
| 826 |
PRODUCT PREPARATION ERROR |
1 |
0.0000 |
| 827 |
CARDIAC ARREST |
4 |
0.0000 |
| 828 |
PULMONARY HYPERTENSION |
1 |
0.0000 |
| 829 |
DERMATITIS |
1 |
0.0000 |
| 830 |
SKIN EXFOLIATION |
4 |
0.0000 |
| 831 |
PLATELET COUNT DECREASED |
5 |
0.0000 |
| 832 |
IMPAIRED WORK ABILITY |
1 |
0.0000 |
| 833 |
POOR QUALITY SLEEP |
1 |
0.0000 |
| 834 |
DEEP VEIN THROMBOSIS |
3 |
0.0000 |
| 835 |
CLOSTRIDIUM DIFFICILE INFECTION |
1 |
0.0000 |
| 836 |
MELAENA |
1 |
0.0000 |
| 837 |
TOOTH DISORDER |
1 |
0.0000 |
| 838 |
DISEASE PROGRESSION |
5 |
0.0000 |
| 839 |
COMA |
2 |
0.0000 |
| 840 |
PRODUCT PRESCRIBING ERROR |
1 |
0.0000 |
| 841 |
OVERDOSE |
9 |
0.0000 |
| 842 |
BLOOD PRESSURE FLUCTUATION |
1 |
0.0000 |
| 843 |
LOCALISED INFECTION |
1 |
0.0000 |
| 844 |
HYPOGLYCAEMIA |
2 |
0.0000 |
| 845 |
RESPIRATORY FAILURE |
3 |
0.0000 |
| 846 |
ENCEPHALOPATHY |
1 |
0.0000 |
| 847 |
AGEUSIA |
1 |
0.0000 |
| 848 |
ABDOMINAL PAIN LOWER |
1 |
0.0000 |
| 849 |
PRODUCT COMPLAINT |
1 |
0.0000 |
| 850 |
CARDIOVASCULAR DISORDER |
1 |
0.0000 |
| 851 |
DRUG RESISTANCE |
1 |
0.0000 |
| 852 |
SKIN ULCER |
1 |
0.0000 |
| 853 |
RASH GENERALISED |
1 |
0.0000 |
| 854 |
SPEECH DISORDER |
2 |
0.0000 |
| 855 |
DRUG INTERACTION |
6 |
0.0000 |
| 856 |
BRADYCARDIA |
2 |
0.0000 |
| 857 |
MENSTRUATION IRREGULAR |
1 |
0.0000 |
| 858 |
THROAT TIGHTNESS |
1 |
0.0000 |
| 859 |
MOOD ALTERED |
1 |
0.0000 |
| 860 |
RESPIRATORY ARREST |
1 |
0.0000 |
| 861 |
PANCYTOPENIA |
2 |
0.0000 |
| 862 |
DEMENTIA |
1 |
0.0000 |
| 863 |
RENAL IMPAIRMENT |
3 |
0.0000 |
| 864 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
1 |
0.0000 |
| 865 |
INTERNATIONAL NORMALISED RATIO INCREASED |
1 |
0.0000 |
| 866 |
DYSPHONIA |
2 |
0.0000 |
| 867 |
BONE PAIN |
2 |
0.0000 |
| 868 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0000 |
| 869 |
ACUTE MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 870 |
URINARY INCONTINENCE |
1 |
0.0000 |
| 871 |
RENAL INJURY |
1 |
0.0000 |
| 872 |
BLOOD POTASSIUM DECREASED |
1 |
0.0000 |
| 873 |
HEPATIC FAILURE |
1 |
0.0000 |
| 874 |
NO ADVERSE EVENT |
6 |
0.0000 |
| 875 |
LACRIMATION INCREASED |
1 |
0.0000 |
| 876 |
CORONARY ARTERY DISEASE |
1 |
0.0000 |
| 877 |
OROPHARYNGEAL PAIN |
3 |
0.0000 |
| 878 |
MOOD SWINGS |
1 |
0.0000 |
| 879 |
MOVEMENT DISORDER |
1 |
0.0000 |
| 880 |
LACTIC ACIDOSIS |
1 |
0.0000 |
| 881 |
EYE DISORDER |
1 |
0.0000 |
| 882 |
BLOOD PRESSURE DECREASED |
2 |
0.0000 |
| 883 |
URINARY RETENTION |
1 |
0.0000 |
| 884 |
NEOPLASM MALIGNANT |
2 |
0.0000 |
| 885 |
TRANSIENT ISCHAEMIC ATTACK |
1 |
0.0000 |
| 886 |
ILLNESS |
3 |
0.0000 |
| 887 |
HEART RATE DECREASED |
1 |
0.0000 |
| 888 |
LYMPHADENOPATHY |
1 |
0.0000 |
| 889 |
WRONG TECHNIQUE IN DRUG USAGE PROCESS |
1 |
0.0000 |
| 890 |
HYPERGLYCAEMIA |
1 |
0.0000 |
| 891 |
INFLUENZA |
3 |
0.0000 |
| 892 |
COLITIS |
1 |
0.0000 |
| 893 |
CHRONIC KIDNEY DISEASE |
2 |
0.0000 |
| 894 |
HYPOTENSION |
5 |
0.0000 |
| 895 |
CARDIAC FAILURE |
2 |
0.0000 |
| 896 |
SOMNOLENCE |
5 |
0.0000 |
| 897 |
EXTRA DOSE ADMINISTERED |
1 |
0.0000 |
| 898 |
LUNG NEOPLASM MALIGNANT |
1 |
0.0000 |
| 899 |
INJECTION SITE ERYTHEMA |
3 |
0.0000 |
| 900 |
RHABDOMYOLYSIS |
1 |
0.0000 |
| 901 |
CARDIO-RESPIRATORY ARREST |
1 |
0.0000 |
| 902 |
RENAL FAILURE ACUTE |
1 |
0.0000 |
| 903 |
HYPOACUSIS |
1 |
0.0000 |
| 904 |
MENTAL DISORDER |
1 |
0.0000 |
| 905 |
COVID-19 |
4 |
0.0000 |
| 906 |
PULMONARY OEDEMA |
1 |
0.0000 |
| 907 |
DEVICE ISSUE |
2 |
0.0000 |
| 908 |
RENAL DISORDER |
1 |
0.0000 |
| 909 |
FALL |
7 |
0.0000 |
| 910 |
DISEASE RECURRENCE |
1 |
0.0000 |
| 911 |
RASH ERYTHEMATOUS |
1 |
0.0000 |
| 912 |
FEELING ABNORMAL |
5 |
0.0000 |
| 913 |
INTERSTITIAL LUNG DISEASE |
1 |
0.0000 |
| 914 |
ATRIAL FIBRILLATION |
2 |
0.0000 |
| 915 |
PRODUCT DOSE OMISSION ISSUE |
6 |
0.0000 |
| 916 |
HEART RATE INCREASED |
2 |
0.0000 |
| 917 |
CHEST DISCOMFORT |
2 |
0.0000 |
| 918 |
ECZEMA |
1 |
0.0000 |
| 919 |
DISTURBANCE IN ATTENTION |
1 |
0.0000 |
| 920 |
HAEMATOCHEZIA |
1 |
0.0000 |
| 921 |
HYPONATRAEMIA |
1 |
0.0000 |
| 922 |
INCORRECT DOSE ADMINISTERED |
4 |
0.0000 |
| 923 |
HERPES ZOSTER |
1 |
0.0000 |
| 924 |
LETHARGY |
1 |
0.0000 |
| 925 |
EYE IRRITATION |
1 |
0.0000 |
| 926 |
NASAL CONGESTION |
1 |
0.0000 |
| 927 |
CATARACT |
1 |
0.0000 |
| 928 |
VERTIGO |
1 |
0.0000 |
| 929 |
DEVICE DIFFICULT TO USE |
1 |
0.0000 |
| 930 |
FEBRILE NEUTROPENIA |
1 |
0.0000 |
| 931 |
DEHYDRATION |
2 |
0.0000 |
| 932 |
MULTIPLE SCLEROSIS RELAPSE |
1 |
0.0000 |
| 933 |
COUGH |
4 |
0.0000 |
| 934 |
DEVICE MALFUNCTION |
1 |
0.0000 |
| 935 |
HALLUCINATION |
1 |
0.0000 |
| 936 |
ACUTE KIDNEY INJURY |
2 |
0.0000 |
| 937 |
INJECTION SITE HAEMORRHAGE |
1 |
0.0000 |
| 938 |
CEREBROVASCULAR ACCIDENT |
2 |
0.0000 |
| 939 |
SUICIDAL IDEATION |
1 |
0.0000 |
| 940 |
BREAST CANCER |
1 |
0.0000 |
| 941 |
CARDIAC DISORDER |
1 |
0.0000 |
| 942 |
SYNCOPE |
1 |
0.0000 |
| 943 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
2 |
0.0000 |
| 944 |
FLUSHING |
1 |
0.0000 |
| 945 |
MALIGNANT NEOPLASM PROGRESSION |
1 |
0.0000 |
| 946 |
ACCIDENTAL EXPOSURE TO PRODUCT |
1 |
0.0000 |
| 947 |
EMOTIONAL DISTRESS |
1 |
0.0000 |
| 948 |
RENAL FAILURE |
1 |
0.0000 |
| 949 |
BLOOD PRESSURE INCREASED |
1 |
0.0000 |
| 950 |
TOXICITY TO VARIOUS AGENTS |
1 |
0.0000 |
| 951 |
MYALGIA |
1 |
0.0000 |